📅 Oct 20, 2026

Acog Practice Bulletin Number 76

ACOG Practice Bulletin Number 76 is a vital resource in obstetrics, providing evidence-based guidance on the management of abnormal placentation, including placenta accreta spectrum disorders. As these conditions become increasingly prevalent due to rising cesarean delivery rates...

📋

Overview

ACOG Practice Bulletin Number 76 is a vital resource in obstetrics, providing evidence-based guidance on the management of abnormal placentation, including placenta accreta spectrum disorders. As these conditions become increasingly prevalent due to rising cesarean delivery rates, healthcare providers must stay informed about best practices to optimize maternal and neonatal outcomes. This bulletin offers comprehensive recommendations on diagnosis, management, surgical considerations, and multidisciplinary approaches, serving as a crucial reference for obstetricians, maternal-fetal medicine specialists, anesthesiologists, and surgical teams. Overview of ACOG Practice Bulletin Number 76 The Practice Bulletin Number 76, issued by the American College of Obstetricians and Gynecologists, consolidates current evidence and expert consensus on abnormal placentation disorders—specifically placenta accreta, increta, and percreta. These conditions involve abnormal adherence or invasion of the placental tissue into the uterine wall, often leading to severe hemorrhage, hysterectomy, and significant morbidity if not managed properly. The bulletin emphasizes the importance of early diagnosis, careful planning, and a multidisciplinary team approach. It also discusses the rising incidence of these conditions, correlating with increased cesarean deliveries, and underscores the need for tailored management strategies based on the extent of placental invasion and maternal-fetal considerations. Diagnosis of Placenta Accreta Spectrum Disorders Ultrasound Evaluation Ultrasound remains the first-line modality for diagnosing abnormal placentation. The bulletin recommends a detailed sonographic assessment in women with risk factors such as prior cesarean delivery, placenta previa, or uterine surgery. Key ultrasound features include: - Loss of the clear zone between the placenta and myometrium - Thinning or disruption of the uterine serosa-bladder interface - Presence of placental lacunae (vascular lakes within the placenta) - Increased vascularity at the uterine-bladder interface - Abnormal placental placode or focal placental bulge Adjunct Imaging Modalities When ultrasound findings are inconclusive, magnetic resonance imaging (MRI) can provide additional detail, especially regarding the depth of invasion and involvement of adjacent structures like the bladder. MRI features suggestive of invasive placentation include: - Dark intraplacental bands on T2-weighted images - Loss of the normal hypointense interface between the uterus and bladder - Evidence of placental tissue extending beyond the uterine serosa Timing of Diagnosis Early diagnosis, ideally in the second trimester (around 18-20 weeks), allows for better planning. Serial ultrasounds enable monitoring of placental invasion and help inform delivery planning to reduce maternal and fetal risks. Management Strategies Prenatal Planning and Delivery A key recommendation of the bulletin is that women with suspected placenta accreta spectrum disorders should be managed in facilities equipped with multidisciplinary teams experienced in complex obstetric surgeries. Planning involves: - Timing delivery at 34-36 weeks gestation, balancing fetal maturity with maternal safety - Scheduling cesarean hysterectomy or conservative management approaches - Ensuring availability of blood products and neonatal intensive care Surgical Management The primary surgical approach is often cesarean hysterectomy with the placenta in situ to prevent massive hemorrhage. However, conservative options may be considered in select cases, such as leaving the placenta in place with subsequent monitoring, especially in women desiring future fertility. Key surgical considerations include: - Use of uterotonics and intraoperative blood salvage - Preoperative placement of balloons in the internal iliac arteries for hemorrhage control - Involving experienced surgical teams, including urologists if bladder invasion is suspected or confirmed Conservative and Fertility-Sparing Options In women who wish to preserve fertility or in cases where hysterectomy is contraindicated, conservative management involves leaving the placenta in situ, combined with adjunct therapies like methotrexate or uterine artery embolization. However, these approaches carry risks of infection, bleeding, and need for subsequent interventions. Postoperative Care and Follow-up Postoperative management includes close monitoring for hemorrhage, infection, and signs of placental tissue resorption or calcification if conservative management was chosen. Long-term follow-up may involve imaging and counseling regarding future pregnancies. Risk Factors and Prevention Major Risk Factors The bulletin highlights several risk factors associated with abnormal placentation: - Prior cesarean delivery (especially multiple cesareans) - Placenta previa diagnosed in the second trimester - Uterine surgeries such as myomectomy or curettage - Advanced maternal age Preventive Measures While not all cases are preventable, strategies to reduce risk include: - Judicious use of cesarean deliveries - Proper management of placental attachment abnormalities detected early - Patient counseling regarding risks in future pregnancies Multidisciplinary Approach and Teamwork Successful management of abnormal placentation relies on a coordinated team involving obstetricians, anesthesiologists, radiologists, urologists, hematologists, and neonatologists. The bulletin advocates for: - Preoperative planning meetings - Clear communication among team members - Availability of resources such as blood bank, surgical equipment, and intensive care units Ethical and Counseling Considerations Women diagnosed prenatally must receive comprehensive counseling regarding: - Risks of hemorrhage, hysterectomy, and potential fertility implications - Delivery timing and location - Possible need for blood transfusions and intensive care - Future pregnancy risks and planning Shared decision-making is emphasized to align management with patient preferences and clinical indications. Recent Advances and Future Directions Recent developments include the use of: - Intraoperative ultrasound guidance - Uterine artery embolization - Novel surgical techniques such as segmental uterine resection - Pharmacologic adjuncts like tranexamic acid Ongoing research aims to improve diagnostic accuracy, refine conservative management protocols, and reduce maternal morbidity. Conclusion ACOG Practice Bulletin Number 76 provides a comprehensive framework for diagnosing and managing placenta accreta spectrum disorders. By emphasizing early detection, multidisciplinary coordination, and individualized care plans, healthcare providers can significantly improve maternal and fetal outcomes. Staying current with these guidelines ensures that clinicians are prepared to address this complex obstetric challenge effectively. --- References: - American College of Obstetricians and Gynecologists. (2018). Practice Bulletin No. 76: Placenta Accreta Spectrum. Obstetrics & Gynecology, 132(1), e31–e47. - Society for Maternal-Fetal Medicine. (2018). Placenta Accreta Spectrum Management. SMFM Consult Series. - Other peer-reviewed articles and clinical guidelines as relevant. --- Keywords: ACOG Practice Bulletin Number 76, placenta accreta, abnormal placentation, placenta increta, placenta percreta, obstetric management, prenatal diagnosis, multidisciplinary team, cesarean hysterectomy
Advertisement
🔎

In-Depth Exploration

Understanding ACOG Practice Bulletin Number 76: A Comprehensive Guide for Obstetric Care

ACOG Practice Bulletin Number 76 stands as a pivotal document issued by the American College of Obstetricians and Gynecologists (ACOG), offering evidence-based guidance on the management of preterm labor and the prevention of preterm birth. As preterm birth remains a leading cause of neonatal morbidity and mortality worldwide, this bulletin serves as an essential resource for clinicians, researchers, and healthcare providers committed to optimizing maternal and neonatal outcomes. This article delves into the core aspects of Practice Bulletin 76, unpacking its recommendations, underlying evidence, and practical implications in contemporary obstetric practice.

Background and Significance of Practice Bulletin Number 76

Preterm birth, defined as delivery before 37 completed weeks of gestation, accounts for approximately 10% of all live births globally. It is associated with a spectrum of complications, including respiratory distress syndrome, intraventricular hemorrhage, necrotizing enterocolitis, and long-term neurodevelopmental impairments. The multifactorial etiology of preterm labor encompasses spontaneous onset, medical indications, and social determinants, making its prevention and management complex. Recognizing these challenges, ACOG issued Practice Bulletin Number 76 in 2017 to synthesize current evidence, update clinical guidelines, and standardize practices related to preterm labor management. The bulletin emphasizes risk assessment, timely diagnosis, intervention strategies, and patient-centered counseling, aiming to reduce the incidence and adverse outcomes associated with preterm birth.

Scope and Objectives of the Practice Bulletin

The primary objectives of the bulletin are to: - Identify women at risk for preterm labor. - Describe diagnostic criteria and tools for early detection. - Outline evidence-based management strategies to prolong pregnancy when appropriate. - Detail the use of pharmacologic and procedural interventions. - Provide guidance on patient counseling and shared decision-making. Its scope encompasses spontaneous preterm labor, preterm premature rupture of membranes (PPROM), and iatrogenic preterm delivery, ensuring comprehensive coverage of the clinical scenarios obstetricians encounter.

Risk Assessment and Identification of Women at Risk

Early identification of women at risk for preterm birth is crucial for implementing preventive measures. The bulletin highlights several risk factors, including: - Prior preterm birth or cervical surgery. - Multiple gestation. - Uterine anomalies. - Maternal infections (e.g., bacterial vaginosis). - Lifestyle factors such as smoking and substance abuse. - Socioeconomic determinants. Screening tools and assessments include: - History-taking to identify previous preterm deliveries. - Transvaginal cervical length measurement via ultrasound. - Fetal fibronectin testing as a biomarker of imminent labor. The document emphasizes that risk assessment should be individualized, integrating clinical history with diagnostic testing to stratify patients effectively.

Diagnostic Criteria and Tools for Preterm Labor

Accurate diagnosis of preterm labor remains a cornerstone of effective management. The bulletin defines preterm labor as regular uterine contractions accompanied by cervical changes between 20 and 36 6/7 weeks gestation. Key diagnostic tools include: - Clinical Evaluation: Assessment of contraction frequency, intensity, and cervical status. - Transvaginal Ultrasound: Measurement of cervical length—shorter cervix indicates increased risk. - Fetal Fibronectin Testing: Presence of fetal fibronectin in cervicovaginal secretions suggests increased likelihood of preterm delivery within 7–14 days. - Laboratory Tests: Limited utility but may assist in ruling out infections or other causes. The bulletin underscores that no single test is definitive; rather, a combination of assessments improves diagnostic accuracy.

Management Strategies to Prevent Preterm Birth

Prevention remains a key focus of Practice Bulletin 76. The guidelines recommend several interventions based on risk stratification:

1. Progesterone Supplementation

- Indications: Women with a history of spontaneous preterm birth or a short cervix (<25 mm) identified via ultrasound. - Forms: Vaginal progesterone gel or suppositories are preferred for their targeted delivery and favorable safety profiles. - Efficacy: Multiple studies demonstrate that progesterone reduces the risk of preterm birth in high-risk women.

2. Cervical Cerclage

- Indications: Women with a history of cervical insufficiency or a very short cervix (<15 mm), especially in the presence of painless cervical dilation. - Procedure: Surgical placement of a suture around the cervix to prevent dilatation. - Evidence: Effective in select cases, particularly when performed before active labor.

3. Lifestyle and Supportive Measures

- Activity restriction remains controversial; current evidence suggests minimal benefit. - Adequate hydration and infection screening are recommended. - Patient education on recognizing early signs of labor.

Interventions for Women in Preterm Labor

When preterm labor cannot be prevented, prompt management aims to delay delivery to allow fetal maturation and administration of corticosteroids.

1. Tocolytic Therapy

- Purpose: To inhibit uterine contractions temporarily. - Agents: Includes nifedipine, magnesium sulfate, indomethacin, and atosiban. - Timing: Usually administered for up to 48 hours to facilitate corticosteroid administration. - Limitations: Not suitable beyond 34 weeks or in certain clinical scenarios like fetal distress or intrauterine infection.

2. Corticosteroid Administration

- Rationale: Accelerates fetal lung maturity, reducing respiratory distress syndrome. - Protocol: Typically two doses of betamethasone administered 24 hours apart. - Timing: Most effective when delivery occurs within 7 days of administration.

3. Antibiotic Use

- Routine prophylactic antibiotics are not recommended unless infection is suspected or PPROM is diagnosed.

Managing Preterm Premature Rupture of Membranes (PPROM)

PPROM complicates approximately 3% of pregnancies and poses risks of infection and preterm labor. Key management points include: - Assessment: Confirm diagnosis, evaluate fetal status, and assess infection risk. - Expectant Management: When appropriate, with close monitoring, corticosteroid administration, and antibiotics. - Delivery Timing: Balancing risks of infection against prematurity; delivery is often indicated if signs of infection or fetal compromise develop.

Patient Counseling and Shared Decision-Making

Effective communication forms the backbone of managing preterm labor. The bulletin emphasizes: - Discussing risks, benefits, and uncertainties associated with interventions. - Providing emotional support and addressing patient concerns. - Tailoring management plans to individual circumstances and preferences. Shared decision-making fosters trust and improves adherence to recommended therapies.

Implementation Challenges and Future Directions

Despite comprehensive guidelines, challenges persist: - Variability in access to diagnostic tools like transvaginal ultrasound. - Differing interpretations of risk factors among clinicians. - Limited resources in low-income settings. Emerging research focuses on novel biomarkers, genetic factors, and personalized medicine approaches to refine risk prediction and intervention strategies. The bulletin also advocates for continued research to evaluate the long-term outcomes of current interventions and to develop innovative preventive measures.

Conclusion: The Impact of Practice Bulletin Number 76 on Obstetric Care

ACOG Practice Bulletin Number 76 represents a cornerstone in evidence-based obstetric practice, providing clarity amid complex clinical scenarios. Its emphasis on risk assessment, preventive interventions, timely diagnosis, and patient-centered care has significantly shaped contemporary management of preterm labor. By integrating these guidelines into routine practice, clinicians can better stratify risk, implement effective prevention strategies, and improve both maternal and neonatal outcomes. As research advances and new technologies emerge, ongoing updates to such practice guidelines will be crucial in the relentless pursuit of reducing preterm birth rates and safeguarding the health of future generations.
❓

Frequently Asked Questions

What is the primary focus of ACOG Practice Bulletin Number 76? ▾
ACOG Practice Bulletin Number 76 provides guidelines on the management of pregestational diabetes mellitus in pregnancy, emphasizing optimal maternal and fetal outcomes.
How does the bulletin recommend screening for diabetes in pregnant women with pregestational diabetes? ▾
The bulletin recommends confirming pregestational diabetes with documented history and laboratory tests such as HbA1c, fasting plasma glucose, or prior diagnosis, rather than routine screening during pregnancy.
What are the key glucose targets during pregnancy according to Practice Bulletin 76? ▾
The recommended glucose targets are fasting glucose less than 95 mg/dL, 1-hour postprandial less than 140 mg/dL, and 2-hour postprandial less than 120 mg/dL to minimize risks.
Does the bulletin discuss the role of insulin therapy in managing pregestational diabetes? ▾
Yes, it emphasizes insulin as the standard treatment for pregestational diabetes during pregnancy, highlighting the importance of individualized insulin regimens to achieve glycemic control.
What are the recommended fetal surveillance strategies in pregnancies complicated by pregestational diabetes? ▾
The bulletin recommends increased fetal surveillance with ultrasound assessments of growth and amniotic fluid, as well as non-stress tests or biophysical profiles starting around 32-34 weeks gestation.
How does Practice Bulletin 76 address the timing of delivery in women with pregestational diabetes? ▾
It suggests that delivery should be planned around 39 weeks if glycemic control is adequate, but earlier delivery may be considered if there are obstetric or fetal indications.
Are there specific recommendations for postpartum management in women with pregestational diabetes? ▾
Yes, the bulletin recommends postpartum glucose assessment, counseling on future diabetes risk, and ongoing management to prevent complications and optimize long-term health.
What are the key multidisciplinary team members involved in managing pregestational diabetes according to the bulletin? ▾
Management involves obstetricians, endocrinologists, diabetes educators, nutritionists, and pediatricians to ensure comprehensive care for both mother and fetus.
🏷️

Related Topics

ACOG Practice Bulletin Number 76 prenatal diagnosis fetal genetic testing amniocentesis chorionic villus sampling genetic counseling fetal anomalies ultrasound maternal serum screening invasive testing